VANGUARD GROUP INC 13D and 13G filings for Immunome, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-01-30 9:57 pm Sale | 2024-12-31 | 13G | Immunome, Inc. IMNM | VANGUARD GROUP INC | 3,003,438 4.810% | -128,130 (-4.09%) | Filing |
| 2024-11-12 3:57 pm Unchanged | 2024-09-30 | 13G | Immunome, Inc. IMNM | VANGUARD GROUP INC | 3,131,568 5.210% | 0 (Unchanged) | Filing |
| 2024-11-04 11:54 am Purchase | 2024-09-30 | 13G | Immunome, Inc. IMNM | VANGUARD GROUP INC | 3,131,568 5.210% | 3,131,568 (New Position) | Filing |